Home
Stock screener
Insider screener
Rankings
Watchlist
Sign in
Create account
Stocks
·
Health care
· Pharmaceutical Preparations
GENB
Generate Biomedicines, Inc.
GENB
United States
Fiscal year ends December
CIK 0002100782
Results filed 6 Aug 2026
Add to watchlist
Overview
Financials
Insiders
Summary
By person
Transactions
What the insiders did
Scheduled selling only
1 month
12 months
120 months
Individual transactions
1
Everything
Bought
Sold at will
On a plan
Out of an exercise
Exercised, kept
Insider
Date
Role
Action
Shares
Price
Amount
Frances Arnold
29 Oct 2026
Director
Sold on a plan
11,409
$16.19
$184.73K
What was left out
Form 4 filings counted
1
Amendments (4/A) skipped
0
Filings about a different issuer
0
Unreadable filings
0
Joint filings
0
Sales on a Rule 10b5-1 plan
1
Sales straight out of an exercise
0
Sales at will
0
Transactions with no price
0
Shares from compensation/vesting
0
History held since
2 Mar 2026